Stocks
Goldman Sachs Reaffirms Neutral Rating for GE HealthCare
Goldman Sachs recently reaffirmed its Neutral rating for GE HealthCare (NASDAQ:GEHC) stock, keeping its price target at $65.00.
The company's current share price is nearly in line with this target at $64.67.
In a series of investor meetings held last week in Boston, Goldman Sachs expressed confidence in GE HealthCare's 2026 organic revenue guidance of 3-4%.
The firm cited trailing order growth, backlog, and planned installations as supporting factors for the outlook.